C21 Investments (CXXIF, $0.21) was a top loser over the last three months, falling -1 to $0.21 per share. A.I.dvisor analyzed 234 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending November 15, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.